Innate Pharma SA Current Trade Receivables
Innate Pharma SA (IPHYF) had Current Trade Receivables of EUR 391.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Receivables
ifrs-full:CurrentTradeReceivables · last filed 2026-04-01
- 2025-12-31: Current Trade Receivables 391.00K EUR.
- 2025-06-30: Current Trade Receivables 363.00K EUR.
- 2024-12-31: Current Trade Receivables 650.00K EUR.
- 2024-06-30: Current Trade Receivables 393.00K EUR.
| Period end | Current Trade Receivables |
|---|---|
| 2025-12-31 | 391.00K EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 363.00K EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 650.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 393.00K EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 15.23M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 2.93M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 3.08M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 8.56M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 846.00K EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 1.47M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 10.59M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 2.82M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 2.52M EUR 20-F · filed 2021-04-27 |